Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01121939 |
|---|---|
| Brief Title: | Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers |
| First Submitted : | May 10, 2010 |
| First Submitted that Met QC Criteria : | May 10, 2010 |
| First Posted : | May 12, 2010 (Estimate) |
| Results First Submitted : | February 26, 2015 |
| Results First Submitted that Met QC Criteria : | August 20, 2015 |
| Results First Posted : | September 23, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 8, 2016 |
| Last Update Posted : | February 5, 2016 (Estimate) |